cefiderocol has been researched along with Empyema--Pleural* in 1 studies
1 other study(ies) available for cefiderocol and Empyema--Pleural
| Article | Year |
|---|---|
Successful prolonged cefiderocol treatment of a chronic left pleural empyema caused by Pseudomonas aeruginosa in a patient affected by COVID-19: a case report.
Topics: Cefiderocol; Cephalosporins; COVID-19; Empyema, Pleural; Humans; Pseudomonas aeruginosa; Pseudomonas Infections | 2021 |